Literature DB >> 12968105

Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice.

Natalie C Direkze1, Stuart J Forbes, Mairi Brittan, Toby Hunt, Rosemary Jeffery, Sean L Preston, Richard Poulsom, Kairbaan Hodivala-Dilke, Malcolm R Alison, Nicholas A Wright.   

Abstract

Myofibroblasts are ubiquitous cells with features of both fibroblasts and smooth muscle cells. We suggest that the bone marrow can contribute to myofibroblast populations in a variety of tissues and that this is exacerbated by injury. To assess this, female mice were transplanted with male bone marrow and the male cells were tracked throughout the body and identified as myofibroblasts. Skin wounding and paracetamol administration were used to assess whether myofibroblast engraftment was modulated by damage. Following radiation injury, a proportion of myofibroblasts in the lung, stomach, esophagus, skin, kidney, and adrenal capsule were bone-marrow derived. In the lung, there was significantly greater engraftment following paracetamol administration (17% versus 41% p < 0.005). Bone-marrow-derived fibroblasts were also found. We suggest that bone marrow contributes to a circulating population of cells and, in the context of injury, these cells are recruited and contribute to tissue repair.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12968105     DOI: 10.1634/stemcells.21-5-514

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  81 in total

1.  Monocyte development inhibitor PRM-151 decreases corneal myofibroblast generation in rabbits.

Authors:  M R Santhiago; V Singh; F L Barbosa; V Agrawal; S E Wilson
Journal:  Exp Eye Res       Date:  2011-09-14       Impact factor: 3.467

2.  [Umbilical cord stromal cells (UCSC). Cells featuring osteogenic differentiation potential].

Authors:  M Eblenkamp; J Aigner; J Hintermair; S Potthoff; U Hopfner; V Jacobs; M Niemeyer; E Wintermantel
Journal:  Orthopade       Date:  2004-12       Impact factor: 1.087

Review 3.  Tomorrow's skeleton staff: mesenchymal stem cells and the repair of bone and cartilage.

Authors:  W R Otto; J Rao
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

Review 4.  Skin wound healing modulation by macrophages.

Authors:  Mathieu P Rodero; Kiarash Khosrotehrani
Journal:  Int J Clin Exp Pathol       Date:  2010-07-25

5.  The tumor stromal microenvironment as modulator of malignant behavior.

Authors:  Charlotte Kuperwasser
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-12       Impact factor: 2.673

6.  Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis.

Authors:  Bo Ri Seo; Priya Bhardwaj; Siyoung Choi; Jacqueline Gonzalez; Roberto C Andresen Eguiluz; Karin Wang; Sunish Mohanan; Patrick G Morris; Baoheng Du; Xi K Zhou; Linda T Vahdat; Akanksha Verma; Olivier Elemento; Clifford A Hudis; Rebecca M Williams; Delphine Gourdon; Andrew J Dannenberg; Claudia Fischbach
Journal:  Sci Transl Med       Date:  2015-08-19       Impact factor: 17.956

7.  Decreased asbestos-induced lung inflammation and fibrosis after radiation and bone marrow transplant.

Authors:  Jamie Levis; Roberto Loi; Kelly J Butnor; Pamela Vacek; Chad Steele; Brooke T Mossman; Daniel J Weiss
Journal:  Am J Respir Cell Mol Biol       Date:  2007-08-02       Impact factor: 6.914

Review 8.  Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles.

Authors:  Brett Hall; Jennifer Dembinski; A Kate Sasser; Matus Studeny; Michael Andreeff; Frank Marini
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

Review 9.  The gastrointestinal tumor microenvironment.

Authors:  Michael Quante; Julia Varga; Timothy C Wang; Florian R Greten
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

Review 10.  Adult stem cell plasticity: will engineered tissues be rejected?

Authors:  Te-Chao Fang; Malcolm R Alison; Nicholas A Wright; Richard Poulsom
Journal:  Int J Exp Pathol       Date:  2004-06       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.